RobertS.Copeland-HalperinMDFACC
Cardiology • New York, NYNuclear Cardiology, Non-Invasive Cardiology, Vascular Medicine
Director of Cardio-Oncology, Northwell Health System
Dr. Copeland-Halperin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7 Seventh Avenue
New York, NY 10011Phone+1 718-470-7330- Is this information wrong?
Summary
- Fellowship trained Cardio-Oncologist specializing the Cardiovascular Care of Patients with Cancer.
Member ACC Cardio-Oncology Leadership Council
Education & Training
Memorial Sloan Kettering Cancer CenterFellow, Cardio-Oncology, Cardio-Oncology, 2019 - 2020
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2016 - 2019- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2013 - 2016
- Icahn School of Medicine at Mount SinaiClass of 2013
- Hamilton CollegeB.A., Psychology, Psi Chi Honor Society, 2001 - 2005
Certifications & Licensure
NY State Medical License 2017 - 2026
PA State Medical License 2018 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Certification Board of Nuclear CardiologyNuclear Cardiology
Awards, Honors, & Recognition
- Fellow of the American College of Cardiology American College of Cardiology, 2020
- Alpha Omega Alpha Icahn School of Medicine at Mount Sinai, 2014
- Gold Humanism Honor Society Icahn School of Medicine at Mount Sinai, 2013
Clinical Trials
- Abatacept in Immune Checkpoint Inhibitor Myocarditis Start of enrollment: 2022 Jun 22
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS Start of enrollment: 2022 Oct 04
- Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors Start of enrollment: 2023 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.Anthony F Yu, I-Hsin Lin, Justine Jorgensen, Robert Copeland-Halperin, Stephanie Feldman, Amare Assefa, Michelle N Johnson, Chau T Dang, Jennifer E Liu, Richard M Stei...> ;Journal of the American Heart Association. 2023 Oct 3
- 22 citationsRacial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer.Mohammed Al-Sadawi, Yasin Hussain, Robert S. Copeland-Halperin, Jonathan N. Tobin, Chaya S. Moskowitz, Chau T. Dang, Jennifer E. Liu, Richard M. Steingart, Michelle N....> ;The American Journal of Cardiology. 2021 Feb 20
- 20 citationsEarly Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer.Robert S. Copeland-Halperin, Mohammed Al-Sadawi, Sujata Patil, Jennifer E. Liu, Richard M. Steingart, Chau T. Dang, Anthony F. Yu> ;JAMA Oncology. 2020 Dec 1
- Join now to see all
Authored Content
- Atlas of Imaging in Cardio Oncology: Cardio-Oncology in the COVID-19 EraAugust 2021
Committees
- Member, ACC Cardio Oncology Leadership Council 2021 - Present
Research History
- Research AssistantCardiovascular Division Vascular Medicine Section Brigham and Women's Hospital Boston, MA2007 - 2009
Professional Memberships
- Associate Member
- International Cardio Oncology SocietyMember
- Fellow
Hospital Affiliations
Long Island Jewish Medical CenterNew Hyde Park, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
